Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2021 Feb;8(1):e001574.
doi: 10.1136/openhrt-2021-001574.

Prognostic comparison of atrial and ventricular functional mitral regurgitation

Affiliations
Comparative Study

Prognostic comparison of atrial and ventricular functional mitral regurgitation

Chisato Okamoto et al. Open Heart. 2021 Feb.

Abstract

Objective: Atrial functional mitral regurgitation (A-FMR) has been suggested as a new aetiology of functional MR (MR); however, its prognosis and prognostic predictors are not fully elucidated. Aim of this study was to investigate the prognosis and prognostic predictors of A-FMR in comparison with ventricular functional MR (V-FMR).

Methods: Three hundred and seventy-eight consecutive patients with moderate-to-severe or severe functional MR were studied. Functional MR was classified into V-FMR (N=288) and A-FMR (N=90) depending on the alterations of left ventricle (LV) or left atrium (LA) along with clinical context and diagnosis of ischaemic heart disease or cardiomyopathy.

Results: During a median follow-up of 4.1 (2.0-6.7) years, all-cause mortality, cardiovascular mortality and heart failure (HF) hospitalisation occurred in 98 (26%), 81 (21%) and 177 (47%) patients, respectively, and rates of these events and the composite end point of all-cause mortality and HF hospitalisation were consistently higher in V-FMR than A-FMR (unadjusted HR 1.762 (95% CI 1.250 to 2.438), p<0.001; adjusted HR 1.654 (95% CI 1.027 to 2.664), p=0.038, for the composite end point). Further analysis showed different prognostic predictors between V-FMR and A-FMR; while age and LA volume index were independent prognostic predictors of both V-FMR and A-FMR, systolic blood pressure and B-type natriuretic peptide were also those of V-FMR, and estimated glomerular filtration rate, LV end-systolic dimension and tricuspid regurgitation were also those of A-FMR.

Conclusions: The prognosis of V-FMR was significantly worse than that of A-FMR, and prognostic predictors were different between V-FMR and A-FMR. Our study suggests the importance of discriminating A-FMR and V-FMR, and that different treatment strategies may be considered for each aetiology.

Keywords: echocardiography; heart failure; mitral regurgitation.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Characteristics of atrial and ventricular functional mitral regurgitation and prognostic comparison. (A) Characteristics of atrial functional mitral regurgitation (MR) and ventricular functional MR. (B) Kaplan-Meier analysis for the composite end point of all-cause mortality and heart failure hospitalisation showed that ventricular functional MR had significantly higher event rates compared with atrial functional MR (p=0.001, log-rank). LV, left ventricle.
Figure 2
Figure 2
Kaplan-Meier analysis for all-cause mortality, cardiovascular mortality and heart failure hospitalisation Kaplan-Meier analysis showed that event rates of (A) all-cause mortality, (B) cardiovascular mortality and (C) heart failure hospitalisation were consistently higher in ventricular functional mitral regurgitation (MR) compared with atrial functional MR.
Figure 3
Figure 3
Kaplan-Meier analysis for composite end point stratified by atrial fibrillation. There were no significant differences between atrial functional mitral regurgitation (A-FMR) with and without atrial fibrillation (AF) (p=0.31), while ventricular FMR (V-FMR) with AF had a significantly worse outcome compared with V-FMR with no AF (p=0.011).

References

    1. Rossi A, Dini FL, Faggiano P, et al. . Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy. Heart 2011;97:1675–80. 10.1136/hrt.2011.225789 - DOI - PubMed
    1. Nasser R, Van Assche L, Vorlat A, et al. . Evolution of functional mitral regurgitation and prognosis in medically managed heart failure patients with reduced ejection fraction. JACC Heart Fail 2017;5:652–9. 10.1016/j.jchf.2017.06.015 - DOI - PubMed
    1. Wada Y, Ohara T, Funada A, et al. . Prognostic impact of functional mitral regurgitation in patients admitted with acute decompensated heart failure. Circ J 2016;80:139–47. 10.1253/circj.CJ-15-0663 - DOI - PubMed
    1. Kubo S, Kawase Y, Hata R, et al. . Dynamic severe mitral regurgitation on hospital arrival as prognostic predictor in patients hospitalized for acute decompensated heart failure. Int J Cardiol 2018;273:177–82. 10.1016/j.ijcard.2018.09.093 - DOI - PubMed
    1. Kajimoto K, Sato N, Takano T, et al. . Functional mitral regurgitation at discharge and outcomes in patients hospitalized for acute decompensated heart failure with a preserved or reduced ejection fraction. Eur J Heart Fail 2016;18:1051–9. 10.1002/ejhf.562 - DOI - PubMed

LinkOut - more resources